Extended-duration Anticoagulation
Extended-Duration Anticoagulation is a therapeutic strategy involving the prolonged administration of anticoagulant agents beyond the initial treatment phase to prevent recurrent venous thromboembolism in high-risk patients.
264
Publications
23.2K
Citations
1.6K
Authors
664
Institutions
Publications per year
2017–2026
79
Parents
264
Apixaban for Extended Treatment of Venous Thromboembolism
Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text
Ajay K. Kakkar, Benjamin Brenner, Ola E. Dahl et al. · The Lancet · 2008 · 1.1K citations · Full text
1–5 of 264
1.6K
17
h-index
14
h-index
14
h-index
13
h-index
13
h-index
1–5 of 1.6K
664

McMaster University
Hamilton, Canada
21 h-index
90 publications
22.5K citations

Brigham and Women's Hospital
Boston, United States
17 h-index
75 publications
3.5K citations
Harvard University
Cambridge, United States
17 h-index
98 publications
4.8K citations

St Thomas' Hospital
London, United Kingdom
14 h-index
29 publications
2.3K citations

University of Calgary
Calgary, Canada
12 h-index
35 publications
3.1K citations
King's College London
London, United Kingdom
12 h-index
12 publications
1.2K citations

University of Padua
Padua, Italy
12 h-index
28 publications
7.4K citations
Université Paris Cité
Paris, France
11 h-index
34 publications
2.6K citations
1–8 of 664
25 publications · 1.4K citations
18
h-index
JTH · 13 publications · 1.2K citations
13
h-index
Repository · 12 publications · 386 citations
11
h-index
NEJM · 10 publications · 6.8K citations
10
h-index
10 publications · 264 citations
10
h-index
1–5